Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Cancer Research

• Publication date

  1979-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 421210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long term effect of Cis‐Diamminedichloride platinum (CDDP) on renal function and structure in man

  1978cited by this paper
• Current concepts on the pathophysiology of acute renal failure.

  1978cited by this paper
• Improvement of Cis‐dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model

  1977cited by this paper
• Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide.

  1977cited by this paper
• Modification of the renal toxicity of cis-dichlorodiammineplatinum(II) with furosemide in male F344 rats.

  1977cited by this paper
• Cis-diamminedichloroplatinum (II). A new anticancer drug.

  1977cited by this paper
• Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.

  1977cited by this paper
• Use of 99mTc-Cu-DTPA complex as a renal function agent.

  1977cited by this paper
• Analysis for platinum in biological material by flameless atomic absorption spectrometry.

  1977cited by this paper
• Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine.

  1977cited by this paper
• Pathophysiology of acute renal failure.

  1977cited by this paper
• The renal pathology in clinical trials of Cis‐platinum (II) diamminedichloride

  1977cited by this paper
• High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis

  1977cited by this paper
• The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats.

  1976cited by this paper
• Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay.

  1976cited by this paper
• Nephrotoxicity of paraquat in mice.

  1975cited by this paper
• cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.

  1973cited by this paper
• Maintenance of renal function in salt loaded rats despite severe tubular necrosis induced by HgCl 2 .

  1971cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• Glomerular filtration and renal plasma flow in uranium-poisoned rabbits.

  1971cited by this paper
• Ototoxicity induced by furosemide.

  1970cited by this paper
• Single-injection clearances of iothalamate-131-I in the rat.

  1970cited by this paper
• Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).

  1970cited by this paper
• Measurement of renal function in the rat with single injection clearances.

  1967cited by this paper
• Rapid determination of urea nitrogen in serum or plasma without deproteinization.

  1967cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Phase II Study of Short Hydration without Diuretics for Cisplatin-Based Chemotherapy.

  2025cites this paper
• Guidance on the short hydration method for cisplatin administration

  2025cites this paper
• Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration: A randomized phase II trial

  2024cites this paper
• Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity

  2024cites this paper
• Effect of Mannitol on Cisplatin-Associated AKI: A Target Trial Emulation.

  2024cites this paper
• Hyponatremia timing, incidence, and associated risk factors in patients treated with cisplatin for lung cancer: a retrospective study.

  2022cites this paper
• Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy

  2020cites this paper
• Raman spectroscopy: A novel experimental approach to evaluating cisplatin induced tissue damage.

  2020cites this paper
• Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial

  2020cites this paper
• Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial

  2019cites this paper
• Renoprotective effect of the isoflavonoid biochanin A against cisplatin induced acute kidney injury in mice: Effect on inflammatory burden and p53 apoptosis

  2018cites this paper
• Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial

  2018cites this paper
• Furosemide versus mannitol in patients who received cisplatin-based chemotherapy using short hydration: study protocol for a randomized controlled trial

  2018cites this paper
• Renal toxicity and chemotherapy in children with cancer

  2017cites this paper
• An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

  2016cites this paper
• Curcuma comosa ameliorates cisplatin-induced nephrotoxicity: COX-2 expression and ultrastructure changes

  2016cites this paper
• Renal Effects of Glucose Transporter 4 in Nω‐nitro‐L‐arginine /High Salt Induced‐Hypertensive Rats

  2015cites this paper
• Biotoxicity of Chemotherapy

  2014cites this paper
• [Impact of lung cancer treatments on renal function].

  2014cites this paper
• Toxicity to Host-renewing Cell Populations in Rats Cis-Dichlorodiammineplatinum(II) Antitumor Activity and Effects of Mannitol or Furosemide Diuresis on

  2013cites this paper
• Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002.

  2013cites this paper
• Short hydration in chemotherapy containing cisplatin (≥75 mg/m2) for patients with lung cancer: a prospective study.

  2013cites this paper
• Complications associated with chemotherapy in testicular cancer management

  2011cites this paper
• [Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].

  2010cites this paper
• Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

  2008cites this paper
• Cisplatin: a review of toxicities and therapeutic applications.

  2008cites this paper
• EFFECTS OF HYPERBILIRUBINEMIA ON CISPLATIN NEPHROTOXICITY By KARRI ANN BARABAS A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA

  2007cites this paper
• Synthesis and Anchoring of Antineoplastic Ferrocene and Phthalocyanine Derivatives on Water-Soluble Polymeric Drug Carriers Derived from Lysine and Aspartic Acid

  2007cites this paper
• New imidazole-coordinated chemotherapeutics with low epithelial toxicity

  2006cites this paper
• Morphological and histochemical evidence of the protective effect of procainamide hydrochloride on tissue damage induced by repeated administration of low doses of cisplatin.

  2005cites this paper
• Cumulative renal tubular damage associated with cisplatin nephrotoxicity

  2004cites this paper
• Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum

  2004cites this paper
• Cisplatin nephrotoxicity

  2004cites this paper
• Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration

  2004cites this paper
• Urinary β2-microglobulin early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide

  2004cites this paper
• Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine

  2004cites this paper
• Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats

  2004cites this paper
• Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP)

  2004cites this paper
• Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review

  2004cites this paper
• WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach

  2004cites this paper
• Reduction of lethal toxicity of chloroethylnitrosoureas by sugar alcohols without loss of antitumor activity

  2004cites this paper
• Platinum‐based anticancer agents: Innovative design strategies and biological perspectives

  2003cites this paper
• Cisplatin nephrotoxicity.

  2003cites this paper
• Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats.

  2001cites this paper
• Effect of spironolactone on cisplatininduced nephrotoxicity in rabbits

  2001cites this paper
• Potentiation of cisplatin-induced nephrotoxicity in rats by allopurinol.

  2000cites this paper
• Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance.

  1999cites this paper
• Trace metals in patients with acute renal failure

  1998cites this paper
• Anticancer: Cisplatin/carboplatin

  1998cites this paper
• Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

  1997cites this paper
• Cisplatin‐induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels

  1997cites this paper
• N-acetyl cysteine ameliorates ischemic renal failure.

  1997cites this paper
• The renal clearance of unchanged cisplatin during furosemide and mannitol diuresis is dependent on glomerular filtration rate in rats.

  1996cites this paper
• Protective action of ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility.

  1996cites this paper
• Protective Role of Vitamin E and Acetazolamide in Cisplatin-Induced Changes in Lipid Peroxidation and Antioxidant Enzyme Levels in Albino Rats

  1996cites this paper
• Protective effect of sodium L-malate, an active constituent isolated from Angelicae radix, on cis-diamminedichloroplatinum(II)-induced toxic side effect.

  1994cites this paper
• Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin.

  1993cites this paper
• Combined Effects of Noise and Cisplatin: Short- and Long-Term Follow-Up

  1992cites this paper
• Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.

  1992cites this paper
• Renal accumulation and urinary excretion of cisplatin in diabetic rats.

  1991cites this paper
• Acute renal failure associated with the use of intraperitoneal carboplatin: A report of two cases and review of the literature

  1991cites this paper
• Long-Term Complications of Antineoplastic Agents

  1991cites this paper
• Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.

  1991cites this paper
• Acute renal failure associated with the use of intraperitoneal carboplatin: a report of two cases and review of the literature.

  1991cites this paper
• Cisplatin‐based chemotherapy in a renal transplant recipient

  1991cites this paper
• IN VITRO ANTITUMOR ACTIVITY OF A NEW PLATINUM ANALOGUE, NK 121 AGAINST FRESH HUMAN TUMOR CELLS AND ESTABLISlIED TUMOR CELL LINES BY SUCCINATE DEHYI)ROGENASE INHIBITION TEST

  1990cites this paper
• Pharmacological interaction with quinoid antitumor drugs.

  1990cites this paper
• Cisplatin nephrotoxicity: experimental and clinical studies.

  1990cites this paper
• ウリナスタチン（ミラクリッド）によるシスプラチン腎毒性の軽減作用

  1990cites this paper
• Improved therapeutic index of cisplatin by procaine hydrochloride.

  1990cites this paper
• Long‐term effects of acetazolamide and sodium chloride loading on cisplatin nephrotoxicity in the rat

  1990cites this paper
• [Pharmacotherapy and kidney function].

  1989cites this paper
• The combined effect of cisplatin and furosemide on hearing function in guinea pigs.

  1989cites this paper
• Interactions between anticancer drugs and other clinically used pharmaceuticals. A review.

  1989cites this paper
• Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats

  1989cites this paper
• Platinum—Amine Complexes as Anticancer Agents

  1989cites this paper
• Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity.

  1989cites this paper
• The Effect of Acetazolamide and Furosemide on Lithium Clearance and Cisplatin Nephrotoxicity in the Rat

  1989cites this paper
• Clinical Management of Cytotoxic Drug Overdose

  1988cites this paper
• Sodium thiosulfate prevents cisplatin-induced hypomagnesemia.

  1988cites this paper
• Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.

  1988cites this paper
• Drug-induced tubulo-interstitial nephritis: special cases.

  1988cites this paper
• The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.

  1988cites this paper
• Evolution of high-dose cisplatin

  1988cites this paper
• Supplemental Fosfomycin and/or Steroids that Reduce Cisplatin‐Induced Nephrotoxicity

  1988cites this paper
• Cisplatin Efficacy and Toxicity: Are they Separable?

  1988cites this paper
• Postoperative complications after adjuvant surgery for lung cancer

  1988cites this paper
• Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues.

  1987cites this paper
• The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.

  1987cites this paper
• Protection from acute renal failure.

  1987cites this paper
• Clinical and Experimental Nephrotoxicity of Cancer Chemotherapeutic Agents

  1987cites this paper
• Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex.

  1987cites this paper
• Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kinetics

  1987cites this paper
• Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys.

  1987cites this paper
• Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat.

  1987cites this paper
• Pharmacokinetic Drug Interactions of Commonly Used Anticancer Drugs

  1986cites this paper
• Cisplatin nephrotoxicity.

  1986cites this paper
• Outpatient administration of VP-16 and cisplatin.

  1986cites this paper
• [Renal complications of anti-cancer chemotherapy].

  1986cites this paper
• Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.

  1986cites this paper